In-hospital and on-discharge treatment patterns stratified by sex
| No/total no (%) | P value | |||
| Total (n=21 374) | Women (n=5191) | Men (n=16 183) | ||
| Medications | ||||
| Prehospital aspirin | 3796/21 352 (17.8) | 948/5186 (18.3) | 2848/16 166 (17.6) | 0.28 |
| In-hospital aspirin | 20 885/21 328 (97.9) | 5044/5171 (97.5) | 15 841/16 157 (98.0) | 0.033 |
| In-hospital second antiplatelet | 20 973/21 347 (98.2) | 5071/5180 (97.9) | 15 902/16 167 (98.4) | 0.028 |
| In-hospital β-blocker | 8314/20 759 (40.1) | 2049/5009 (40.9) | 6265/15 750 (39.8) | 0.16 |
| In-hospital anticoagulant | 18 256/21 332 (85.6) | 4421/5177 (85.4) | 13 835/16 155 (85.6) | 0.67 |
| Studies and procedures | ||||
| Echocardiography | 19 725 (92.3) | 4777/5191 (92.0) | 14 948/16 183 (92.4) | 0.42 |
| Diagnostic angiography | 12 681 (59.3) | 2638/5191 (50.8) | 10 043/16 183 (62.1) | <0.001 |
| PCI | 10 553 (49.4) | 2067/5191 (39.8) | 8486/16 183 (52.4) | <0.001 |
| Primary PCI (STEMI) | 6710/13 689 (49.0) | 1307/2846 (45.9) | 5403/10 843 (49.8) | <0.001 |
| Door-to-balloon time (STEMI), median (IQR), min | 83 (57–190) (n=9462) | 90 (60–270) (n=1874) | 80 (55–180) (n=7588) | <0.001 |
| Thrombolysis (STEMI) | 3167/13 689 (23.1) | 635/2846 (22.3) | 2532/10 843 (23.4) | 0.25 |
| Door-to-needle time (STEMI), median (IQR), min | 44 (30–70) (n=2888) | 45.5 (30–75) (n=594) | 43 (29–70) (n=2294) | 0.001 |
| Any reperfusion (STEMI) | 9872/13 689 (72.1) | 1942/2846 (68.2) | 7930/10 843 (73.1) | <0.001 |
| Rescue PCI | 1675/13 659 (12.3) | 308/2841 (10.8) | 1367/10 818 (12.6) | 0.009 |
| Discharge treatment and counselling | ||||
| Discharge aspirin | 19 137/19 557 (97.9) | 4448/4603 (96.6) | 14 689/14 954 (98.2) | <0.001 |
| Discharge second antiplatelet agent | 19 201/19 591 (98.0) | 4509/4620 (97.6) | 14 692/14 971 (98.1) | 0.026 |
| Discharge β-blocker | 12 607/19 072 (66.1) | 2963/4470 (66.3) | 9644/14 602 (66.0) | 0.77 |
| Discharge statin | 18 989/19 585 (97.0) | 4460/4625 (96.4) | 14 529/14 960 (97.1) | 0.019 |
| Discharge ACE inhibitor or ARB | 9232/19 193 (48.1) | 2182/4516 (48.3) | 7050/14 677 (48.0) | 0.75 |
| Cardiac rehabilitation referral | 5684/20 019 (28.4) | 1363/4711 (28.9) | 4321/15 308 (28.2) | 0.36 |
ACE inhibitor, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; IQR, interquartile range; PCI, percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction.